Aims: The DIRECT study is a first-in-human evaluation of the safety and efficacy of the Svelte sirolimus-eluting coronary stent mounted on a fix
1. Auckland City Hospital, Auckland, New Zealand; 2. Wellington Hospital, Wellington, New Zealand; 3. Christchurch Hospital, Christchurch, New Zealand;4. Ascot Angiography, Auckland, New Zealand
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
coronary artery diseasedirect stentingdrug-eluting stentspercutaneous coronary intervention
Read next articleEarly or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial